Search - tctmd.com

Displaying 1 - 20 of 250

Sort: Relevancy | Date

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Yael L. Maxwell

September 06, 2023

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

News Daily News

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

L.A. McKeown

October 28, 2021

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

Todd Neale

July 26, 2021

News Daily News

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

Caitlin E. Cox

January 07, 2021

News Daily News

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Todd Neale

August 12, 2020

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

Todd Neale

January 02, 2019

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

Advertisement

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Tailored TAVI: Standardizing Balloon Pressures May Curb Operator Angst

3M TAVR: Minimalist TAVI Pathway Saves Money

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content